Ubiquitination-proteomics in mouse primary macrophages
Ontology highlight
ABSTRACT:
ORGANISM(S): Mus Musculus
SUBMITTER: 
Lei Qiang
PROVIDER: PXD045946 | iProX | Fri Oct 06 00:00:00 BST 2023
REPOSITORIES: iProX
Similar Datasets
Project description:We performed proteomic analysis of di-Gly peptides to identify which proteins are ubiquitinated in cells overexpressing TFEB compared to non-expressing cells.
2025-11-18 | PXD065497 | Pride
Project description:To confirm that Ser137 of Sec22b is phosphoribosyl-ubiquitinated, we investigated both non-modified Sec22b and modified Sec22b using MS/MS analysis.
2025-11-05 | PXD067293 | JPOST Repository
Project description:To determine the ubiquitinated sites on PRDX4, we analyzed ubiquitinated PRDX4 via MS, revealing modifications at six lysine residues. Point mutation analysis confirmed that K265 residue is the primary site for ARIH1-mediated PRDX4 ubiquitination. The K265 mutation (K265R) almost abolished PRDX4 ubiquitination in vitro, confirming the critical role of this residue in regulating PRDX4 ubiquitination.
2026-01-29 | PXD073745 |
Project description:By hyperosmotic stimuli, a slight increase in the level of ubiquitylated proteins was observed. So we tried to identify the di-Gly peptides.
2020-02-18 | PXD016369 | Pride
Project description:Determination of ubiquitination sites on an artificial substrate consisting of an Neh2 domain from Nrf2 that has been modified to be able to be ubiquitinated with three different E3 ligase systems, Ubr1 (which forms K48 linkages), Rsp5 (which forms K63 linkages) and Cul3/Rbx1/Keap1 (which forms branched linkages).
2024-01-05 | MSV000093780 | MassIVE
Project description:We here apply the COmbined FRActional DIagonal Chromatography (COFRADIC) technology to enrich for ubiquitinated peptides and identify sites of ubiquitination by mass spectrometry. Our technology bypasses the need to ectopically overexpress tagged variants of ubiquitin and the use of sequence-biased antibodies recognizing ubiquitin remnants. In brief, all protein primary amino groups are blocked by chemical acetylation after which ubiquitin chains are proteolytically and specifically removed by the catalytic core domain of the USP2 deubiquitinase (USP2cc). As USP2cc cleaves the isopeptidyl bond between the ubiquitin C-terminus and the ɛ-amino group of the ubiquitinated lysine, this enzyme re-introduces primary ɛ-amino groups in proteins. These amino groups are then chemically modified with a handle that allows specific isolation of ubiquitinated peptides during subsequent COFRADIC chromatographic runs. Our method allowed us to identify over 8,200 endogenous ubiquitination sites in more than 3,600 different proteins in a native human Jurkat cell lysate.
2016-07-08 | PXD000934 | Pride
Project description:We here apply the COmbined FRActional DIagonal Chromatography (COFRADIC) technology to enrich for ubiquitinated peptides and identify sites of ubiquitination by mass spectrometry. Our technology bypasses the need to ectopically overexpress tagged variants of ubiquitin and the use of sequence-biased antibodies recognizing ubiquitin remnants. In brief, all protein primary amino groups are blocked by chemical acetylation after which ubiquitin chains are proteolytically and specifically removed by the catalytic core domain of the USP2 deubiquitinase (USP2cc). As USP2cc cleaves the isopeptidyl bond between the ubiquitin C-terminus and the ?-amino group of the ubiquitinated lysine, this enzyme re-introduces primary ?-amino groups in proteins. These amino groups are then chemically modified with a handle that allows specific isolation of ubiquitinated peptides during subsequent COFRADIC chromatographic runs. Our method allowed us to identify over 8,200 endogenous ubiquitination sites in more than 3,600 different proteins in a native human Jurkat cell lysate.
2017-03-29 | MSV000080780 | MassIVE
Project description:The reversible attachment of ubiquitin governs the interaction, activity and degradation of proteins whereby the type and target of this conjugation determine the biological response. The investigation of this complex and multi-faceted protein ubiquitination mostly relies on painstaking biochemical analyses. Here, we employ recombinant binding domains to identify the UHRF1 dependent ubiquitinated proteins by liquid chromatography tandem mass spectrometry (LC-MS/MS).
2023-01-30 | PXD034335 | Pride
Project description:We report whole genome chromatin immunoprecipitation followed by sequencing (ChIP-seq) of histone modifications in MCF-7 breast cancer cells treated with vehicle (UNTR) or the proteasome inhibitor MG132 for 4 (MG4H) or 24 (MG24H) hours. We find that MG132 treatment results in the spreading of the H3-trimethyl lysine 4 mark into gene bodies of a subset of induced genes in MCF-7 cells. The spreading of the H3K4me3 is concomitant with hyperacetylation (H3K27ac, K122ac and K9/14ac) of the corresponding gene TSS. H3 Lysine 36 trimethylation mark is enriched at genes that are induced by MG132. Finally, we show that proteasome inhibition establishes a chromatin state that enhances antiproliferative, while dampening cell proliferative gene expression programs relevant to breast cancer. The study provides a comprehensive resource of histone modifications in proteasome inhibited cells.
2020-01-07 | GSE142009 | GEO
Project description:While defective α-synuclein homeostasis is central to the pathogenesis of Parkinson’s, fundamental questions about its intracellular trafficking remain unresolved. We have developed a bimolecular fluorescence complementation assay in living cells to monitor de novo ubiquitination of α-synuclein. We identified lysine residues 45, 58 and 60 as critical ubiquitination sites for the degradation of α-synuclein. This is mediated by NBR1 binding to ubiquitinated α-synuclein and entry into endosomes in a process that involves ESCRT I-III complexes for subsequent lysosomal degradation. Autophagy or the autophagic chaperone Hsc70 are dispensable for this pathway. Antibodies against diglycine-modified α-synuclein peptides confirmed that endogenous α-synuclein is similarly ubiquitinated in brain and targeted to the lysosome in rat primary and human iPSC-derived neurons. Ubiquitinated α-synuclein was detected in Lewy bodies and cellular models of aggregation suggesting that it may be entrapped with endo/lysosomes in inclusion bodies. Collectively, our data elucidate the intracellular trafficking of de novo ubiquitinated α-synuclein and provide the tools for investigating the rapidly turned-over fraction of this disease-causing protein.
2023-05-17 | PXD038364 | Pride